
Purdue Pharma Looking To Settle Opioid Lawsuits
Why Big Pharma wants to keep these opioid lawsuits out of court.

Why Big Pharma wants to keep these opioid lawsuits out of court.

NASHVILLE, Tenn. (AP) — A new lawsuit invokes the plight of a baby born dependent on opioid drugs, as three Tennessee prosecutors and the baby’s

A class action suit against the infamous OxyContin pushers ended with Purdue Pharma agreeing to fork over $20 million—a drop in the bucket for this

One local newspaper said that this first-of-its-kind lawsuit reads like Everett, Washington is suing Mexican drug lord El Chapo Guzman, rather than Purdu Pharma, which turned

Why Big Pharma wants to keep these opioid lawsuits out of court.

NASHVILLE, Tenn. (AP) — A new lawsuit invokes the plight of a baby born dependent on opioid drugs, as three Tennessee prosecutors and the baby’s guardian accuse several drug manufacturers of unleashing an epidemic through deceptive marketing that downplayed the risks of addiction to painkillers. “Baby Doe spent his first days in the neonatal intensive care unit writhing in agony

A class action suit against the infamous OxyContin pushers ended with Purdue Pharma agreeing to fork over $20 million—a drop in the bucket for this billionaire company that single-handedly started the American opiate epidemic. The Canadian lawsuit involved allegations of “over-marketing,” which happens to be Purdue’s modus operandi, AKA, flooding the market (including knowingly supplying the black market) with their

One local newspaper said that this first-of-its-kind lawsuit reads like Everett, Washington is suing Mexican drug lord El Chapo Guzman, rather than Purdu Pharma, which turned a blind eye for years to the black market distribution of its highly addictive OxyContin in order to “reap large and obscene profits.” Now, the City of Everett is proving this outrage in court and
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!
